Clinical Glutathione

General Statements: All Other Content

PROVEN ACTIVE FORM

Brand IP Statement(s) re: (c), (TM), (SM)

Sublinthion PATENTED PROTECTION SYSTEM

Formula re: Contains

Patented, Reduced Oral Glutathione for Vital Support

General Statements: All Other Content

230% Greater Blood Ratios

General Statements: All Other Content

Proven Stability - 230% Improvement

FDA Statement of Identity

Dietary Supplement

Seals/Symbols

V VEGAN

FDA Disclaimer Statement

This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

General: Product/Version Code

JC 34 91 + 3(5,6)EP BX73706.02

Brand IP Statement(s) re: (c), (TM), (SM)

Product of France French Patent #FR2972327

Brand IP Statement(s) re: (c), (TM), (SM)

Sublinthion is a unique, protected, patented process from France. In a human study, Clinical Glutathione with Sublinthion improved the reduced glutathione vs. oxidized ratios in the body by 230%.*

Brand IP Statement(s) re: (c), (TM), (SM)

{Chart} Clinical Glutathione Unprotected Glutathione +230% Blood ratios of active glutathione to oxidized glutathione between day 1 and day 21 after supplementation.

General Statements: All Other Content

Blood GSH/GSSG ratio compared to unprotected glutathione

Formulation re: Does NOT Contain

No sugar, salt, wheat, gluten, corn, soy, dairy products, artificial coloring, or artificial preservatives.

Suggested/Recommended/Usage/Directions

Recommendations: Take 2 tablets daily. One tablet in a.m. and one tablet in the p.m., or as recommended by your healthcare practitioner. Tablet should be held in mouth and allowed to dissolve before swallowing for optimal results.

Precautions re: Pregnant or Nursing or Prescription Medications

If pregnant or nursing, consult a healthcare practitioner before using.

General Statements: All Other Content

This formula has been clinically studied.